You are here

Home ยป Company Details

LAMBDA PHARMACEUTICALS

Company Information
Address
1500 SAN JUAN HILLS, STE 203
LAS VEGAS, NV 89134
United States
Information

UEI: N/A

# of Employees: N/A
Ownership Information

HUBZone Owned: No

Socially and Economically Disadvantaged: No

Woman Owned: No

Award Charts




Award Listing

  • Record 1 TO 4

  1. Choroidal Neovascular Occlusion Using PDT

    Amount: $100,000.00

    DESCRIPTION (From the Applicant's Abstract): Photodynamic therapy (PDT) is a new potential treatment of the subfoveal choroidal neovascularization ( ...

    SBIRPhase I2001Department of Health and Human Services National Institutes of Health

  2. N/A

    Amount: $100,000.00

    N/A

    SBIRPhase I2000Department of Health and Human Services National Institutes of Health

  3. PHOTOFENTON REAGENTS AS PDT SENSITIZERS

    Amount: $99,053.00

    N/A

    STTRPhase I1998Department of Health and Human Services

  4. COST EFFECTIVE PHOTOSENSITIZERS FOR USE IN PDT

    Amount: $98,975.00

    Photodynamic therapy has been approved for certain indications in the USA, Japan, Canada, France and Netherlands. The only drug approved, Photofrin, is not ideal and a significant research effort has ...

    SBIRPhase I1997Department of Health and Human Services
US Flag An Official Website of the United States Government